|
|||||||||||||||||||||||||||
耐激素
steroid-resistant
Clinical study of early steroid-resistant acute rejection after renal transplantation 肾移植术后早期耐激素急性排斥反应的临床研究 短句来源 Clinical effect of FK506 on the treatment of steroid-resistant rejection after kidney transplantation 他克莫司治疗肾移植术后耐激素性排斥反应的临床观察 短句来源 Methods:34 steroid - resistant patients were treated with ATG who had rejection during hormone impact treatment within 3 days after transplantation or resistant response 3 days after kidney transplantation. 方法:对34例尸体肾移植术后3d内应用激素冲击治疗期间发生排斥反应的患者以及手术3d后发生耐激素排斥反应的患者采用ATG治疗。 短句来源 Low-dose and short-term antithymocyte globulin in treatment of steroid-resistant rejection after renal transplantation 低剂量短疗程抗胸腺细胞球蛋白治疗肾移植耐激素排斥反应 短句来源 Objective:To observe the effect of antithymocyte globulin( ATG) on early steroid - resistant rejections after kidney transplantation. 目的:观察抗胸腺细胞球蛋白(ATG)治疗肾移植术后早期耐激素排斥反应的效果。 短句来源 更多 “耐激素”译为未确定词的双语例句
Methods The OKT3 treatment of 12 cases of refactory renal allograft rejection was studied retrospectively. 方法采用回顾性分析,对12例肾移植术后耐激素性排斥反应患者应用OKT3治疗。 短句来源 RESULTS The reverse rate of rejection was 82 35%(14/17) in AR, 78 57%(11/14) in steroid resistant AR, 100%(10/10) in AAR and 0%(0/2) in HAR. ③获得以上各种情况的治疗总剂量与总时限。 结果：①ATG对肾移植术后AR的逆转率为82．35％（14／17），对耐激素性AR的逆转率为78．57％（11／14），对AAR的逆转率为100％（10／10）； 短句来源 Conclusion OKT3 could effectively treat refractory renal allograft rejection. 结论耐激素性排斥反应使用OKT3治疗效果显著。 短句来源 Results After the use of FK506, steroid resistant rejection was reversed in 23 cases ( 88.46%) within 8～15 days and the remaining 3 patients not recovered were cured by the adoption of plasma exchange and the application of OKT3. The renal function were recovered in all of the patients, but hyperglycosemia occurred in 3 cases. 结果 本组 2 6例耐激素性排斥经改用FK5 0 6后 ,2 3例分别在 8～ 15d逆转 ,肾功能恢复正常 ,治愈率 88.46 % (2 3/2 6 )。 3例治疗效果不佳 ,使用血浆置换治疗和OKT35mg/d× 5d后排斥逆转。 短句来源 Conclusion McAb T3 and McAb T4 had satisfactory therapeutic effects on acute rejection following renal transplantation. 结论 WuT3 、WuT4 对肾移植后急性排斥反应， 包括耐激素急性排斥反应具有较为满意的治疗效果。 短句来源 更多 相似匹配句对
hormone 激素 短句来源 Pathogenesis of Steroid-resistance 原发性肾病综合征激素耐药机制探讨 短句来源 Environmental Hormones 环境激素 短句来源 The Relationship between Tomato (Lycopersicum Esculentum Mill.) Hormone Contentsand the Temperature Stress Tolerance 番茄内源激素含量与其耐温度胁迫的关系 短句来源 Paint with the Deep-Drawing Resistance 耐深冲漆 短句来源 
查询“耐激素”译词为用户自定义的双语例句
我想查看译文中含有：的双语例句 
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法，我们为您准备了出自英文原文的大量英语例句，供您参考。 steroid-resistant
Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute dis
例句来源
Severe steroid-resistant post-infectious encephalomyelitis
例句来源
Factors influencing treatment effectiveness, possible alternative options for steroid-resistant cases, and their outcome profiles, remain unclear.
例句来源
We observed that steroid-resistant patients showed high prevalence of PNS damage (89%) and myelitis (95 %).
例句来源
We conclude that IVIg can be useful in a portion of patients with severe steroid-resistant ADEM and prominent motor dysfunction.
例句来源 更多 
steroid-resistant rejection (SRR)patients after kidney transplantation were treated with ATG(rabbit antithymocyte globulin)in a dose of 2～4mg/(kg·d)for a period of 3～6 days. 18 of them resumed renal function and theirserum creatinine droped from 51. 5mg/L to 21.0mg/L with a one year graft survivalrate of 83.3%. Sincethere is no significant difference in one year graft survival ratebetween ATG-treated group(83.3%) and steriod-responded group(86%),so ATG ap-pear to be an effective agent for SRR patients. 对接受三联免疫抑制治疗（环孢素＋硫唑嘌呤＋皮质激素）的连续１４５例尸体肾移植中，发现２８例耐激素排斥反应，其中２２例应用抗Ｔ细胞球蛋白（ＡＴＧ）治疗。ＡＴＧ２～４ｍｇ／（ｋｇ·ｄ）加入２５０ｍｌ生理盐水于８ｈ内缓慢静滴３～６ｄ，其中１８例肾功能恢复正常。这些患者平均血肌酐由治疗前的５１．５ｍｇ／Ｌ降至２１．０ｍｇ／Ｌ，６个月后维持在１９．８ｍｇ／Ｌ。一年移植肾成活率为８３．３％，而同期急性排斥反应应用激素逆转排斥反应患者为８６％。显示ＡＴＧ治疗耐激素排斥反应有效，可以使有耐激素排斥反应的肾移植患者获得极好的肾功能。 文摘来源 OBJECTIVE To evaluated the efficacy of anti thymocyte globulin (ATG) in renal graft rejection. METHODOLOGY Data of 64 administration of ATG in renal graft recipients were studied retrospectively, including 17 in patients with acute rejection(AR), 10 for acute accelerated rejection(AAR), 2 for hyperacute rejection(HAR) and 35 for preventing therapy alternatively. RESULTS The reverse rate of rejection was 82 35%(14/17) in AR, 78 57%(11/14) in steroid resistant AR, 100%(10/10) in AAR and 0%(0/2) in HA... 目的：探讨抗胸腺细胞球蛋白（ＡＴＧ），在肾移植术后的应用价值与前景。方法：对６４例次使用ＡＴＧ的肾移植受者进行回顾性分析，比较其①对急性排异反应（ＡＲ）、急性加速性排异反应（ＡＡＲ）、超急性排异反应（ＨＡＲ）的预防与治疗情况；②对部分肾移植术后因各种原因暂不能使用常规免疫抑制剂者的替代与过渡治疗情况；③获得以上各种情况的治疗总剂量与总时限。结果：①ＡＴＧ对肾移植术后ＡＲ的逆转率为８２．３５％（１４／１７），对耐激素性ＡＲ的逆转率为７８．５７％（１１／１４），对ＡＡＲ的逆转率为１００％（１０／１０）；②ＡＴＧ制品适用于肾移植术后因各种原因暂不能服用常规免疫抑制剂者的替代与过渡治疗；③ＡＴＧ对ＨＡＲ不能起到预防与治疗的作用；④抗ＡＲ的ＡＴＧ治疗总剂量与时限以８００ｍｇ、５天为宜，抗ＡＡＲ的ＡＴＧ治疗总剂量与时限以７００ｍｇ、６天为宜，预防与替代治疗的总剂量与时限以７００ｍｇ、６天为宜。结论：ＡＴＧ适用于肾移植术后ＡＲ与ＡＡＲ的预防与治疗，特别对耐激素性排异反应以及暂时的替代与过渡治疗尤为合适，如果经济状况允许，应提倡使用。 文摘来源 OBJECTIVE To examine the efficacy of half dose OKT3 (2.5 mg) in the treatment of steroidresistant acute renal allograft rejection.METHODOLOGY 25 renal graft recipients who developed steroidresistant acute renal allograft rejection(SRAR) were included in this study. 18 were treated with half dose OKT3 (2.5 mg per day for 10.4±3.1 days) and 7 with full dose OKT3 (5 mg per day for 10.2±2.8 days). RESULTS Reversal rate of SRAR was 88.9% in the halfdose OKT3 treated SRAR patients (16 in 18). The incid... 目的：了解半剂量ＯＫＴ３能否逆转移植肾耐激素型急性排异（ＳＲ－ＡＲ）。方法：对发生ＳＲ－ＡＲ的肾移植受者，采用半剂量ＯＫＴ３治疗，并与全剂量ＯＫＴ３组对照，观察两组的ＳＲ－ＡＲ的逆转率及并发症发生率。结果：半剂量ＯＫＴ３组（ｎ＝１８）ＳＲ－ＡＲ逆转率为８８．９％，ＣＭＶ病发生率为３８．９％、发热６６．７％、寒颤２２．２％、恶心１６．７％、腹泻１１．１％，与全剂量ＯＫＴ３组（ｎ＝７）相比，两组ＳＲ－ＡＲ逆转率及上述各种发生率间差异均不显著，（Ｐ＞０．０５）。结论：半剂量ＯＫＴ３能逆转ＳＲ－ＡＲ。 文摘来源 << 更多相关文摘 
相关查询:
CNKI小工具
在Springer中查有关的英文论文
在知识搜索中查有关耐激素的内容
在数字搜索中查有关耐激素的内容
在概念知识元中查有关耐激素的内容
在学术趋势中查有关耐激素 的内容
CNKI主页
| 设CNKI翻译助手为主页 |
收藏CNKI翻译助手 | 广告服务
2008 CNKI－中国知网
京ICP证040431号
互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号：110 1081725
2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社